Skip to main content
Premium Trial:

Request an Annual Quote

PredictImmune Gains CE-IVD Mark for IBD Test

NEW YORK (GenomeWeb) – PredictImmune has obtained a CE-IVD mark for its debut test for inflammatory bowel disease, the company said today.

By achieving certification for the test, called PredictSure IBD, the Cambridge, UK-based firm can sell it for clinical use across Europe and other geographies that recognize the designation.

PredictSure IBD relies on a 15-biomarker quantitative PCR panel to guide treatment for Crohn's disease and ulcerative colitis. The test, which is run on Roche's LightCycler instrument, can be used to stratify patients according to the severity of their illnesses, thus enabling clinicians to decide on the best therapies.

PredictImmune CEO Paul Kinnon said in a statement that PredictSure IBD, which will be available in January, "will have a direct and significantly positive impact on the quality of treatment and outcomes for patients."

PredictImmune earlier this year pledged to launch PredictSure IBD in 2019. In April, it announced the receipt of £4.3 million ($5.9 million) from the Wellcome Trust to evaluate the use of its test to guide therapy in 400 patients across the UK. The company in May 2017 raised £4.7 million through a Series A financing round that included investors Parkwalk Opportunities, Cambridge Enterprise, and Wren Capital.

Earlier this month, PredictImmune and the Crohn's & Colitis Foundation announced a joint study to provide additional data for PredictSure IBD. The study will involve approximately 100 patients from four centers in the US and will start later this year. The effort is expected to run for two and a half years.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.